Navigation Links
Optimer Reports Fourth Quarter and Fiscal Year 2012 Financial Results
Date:2/28/2013

rcializing fidaxomicin under the trade name DIFICLIR™.  The Company is exploring marketing authorization in other parts of the world where C. difficile has emerged as a serious health problem. Additional information can be found at http://www.optimerpharma.com.

Forward-looking Statements 
Statements included in this press release that are not a description of historical facts are forward-looking statements, including, without limitation, statements related to the implementation and impact of Optimer's commercialization strategy, Optimer's pursuit of new indications for DIFICID, Optimer's on-going education efforts regarding its patient access initiatives and the burden of Clostridium difficile infection and expansion of DIFICID sales or market potential.  Words such as "expect," "anticipate," "will," "could," "would," "project," "intend," "plan," "believe," "predict," "estimate," "should," "may," "potential," "continue," "ongoing" or variations of such words and similar expressions are intended to identify forward-looking statements. The inclusion of forward-looking statements should not be regarded as a representation by Optimer that any of its plans will be achieved. These forward-looking statements are based on management's expectations on the date of this release. Actual results may differ materially from those set forth in this release due to the risks and uncertainties inherent in Optimer's business including, without limitation, risks relating to: Optimer's ability to continue to increase adoption and use of DIFICID, the implementation and success of DIFICID growth initiatives and entry into new markets, whether or not healthcare professionals will prescribe DIFICID, the extent to which DIFICID receives reimbursement coverage from healthcare payors and government agencies, the extent to which DIFICID will be accepted on additional hospital formularies and the timing of
'/>"/>

SOURCE Optimer Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Optimer Pharmaceuticals Board of Directors Appoints Board Chairman, Dr. Henry McKinnell, Chief Executive Officer
2. Optimer Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and Fiscal Year 2012 Financial Results
3. Optimer Pharmaceuticals to Present at Leerink Swann Global Healthcare Conference
4. Optimer Pharmaceuticals to Present at 23rd Annual Oppenheimer Healthcare Conference
5. Optimer Pharmaceuticals to Present at November 2012 Investor Conferences
6. Optimer Pharmaceuticals Reports Third Quarter 2012 Financial Results
7. Optimer Pharmaceuticals to Present at September 2012 Investor Conferences
8. Optimer Pharmaceuticals to Present at the Canaccord Genuity 32nd Annual Growth Conference
9. Optimer Pharmaceuticals Appoints Stephen Newman to Its Board of Directors
10. Optimer Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2012 Financial Results
11. Optimer Pharmaceuticals to Present at the 7th Annual JMP Securities Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... 30, 2015  Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ... Annual Meeting of StockholdersWhen:Tuesday, June 30 at 5:10 p.m. ... Internet.  Simply log onto our website listed above.   ... the live event, a replay of the webcast will ... . ABOUT ISIS PHARMACEUTICALS, INC. ...
(Date:6/29/2015)... June 30, 2015 , Gerresheimer will ... Corning and Gerresheimer enter into a 10-year-supply agreement for ... EUR 196m debt-free Corning and Gerresheimer ... pharmaceutical glass packaging market Gerresheimer,s outlook for the ... future disposal of the tubing business , In ...
(Date:6/29/2015)... 2015  Nevro Corp. (NYSE: NVRO ), a ... solutions for the treatment of chronic pain, today announced ... Officer of Intersect ENT (NASDAQ: XENT ), has ... 28, 2015. For the last seven ... ENT, a company dedicated to improving the quality of ...
Breaking Medicine Technology:Webcast Alert: Corporate Presentation at the 2015 Isis Pharmaceuticals Annual Stockholder Meeting 2Webcast Alert: Corporate Presentation at the 2015 Isis Pharmaceuticals Annual Stockholder Meeting 3Gerresheimer Will Sell Tubing Operations to Corning - Both Will Form a Joint Venture to Accelerate Innovations for Pharmaceutical Glass Packaging Market 2Gerresheimer Will Sell Tubing Operations to Corning - Both Will Form a Joint Venture to Accelerate Innovations for Pharmaceutical Glass Packaging Market 3Nevro Appoints Lisa Earnhardt to its Board of Directors 2
... WASHINGTON, Oct. 19, 2011 Sharon Ladin, director ... Project, issued the following statement regarding the bipartisan, ... today by Sen. Richard Blumenthal (D-Conn.) and Sen. ... to H.R. 2182 and contains provisions to incentivize ...
... The maker of MidNite ® Sleep ... formula, has succeeded in protecting the brand against patent ... president, Holly Rosenthal. Under the terms of the agreement ... Sleep Remedy, and Contract Pharmacal (CPC), a contract manufacturer ...
Cached Medicine Technology:Popular Sleep Supplement Brand Settles Patent Infringement Suit Against Store Brand Manufacturer 2
(Date:6/30/2015)... GA (PRWEB) , ... June 30, 2015 , ... After ... by the U.S. Food and Drug Administration, GlobalSun (TM) — sunscreen specifically formulated for ... with an SPF rating of 35, hits the market just in time to help ...
(Date:6/30/2015)... , ... June 30, 2015 , ... ... the official ready-to-drink sponsor of two leading organizations dedicated to raising worldwide awareness ... (SAR). , I AM ADAPTIVE™ is now the official charity of FitAID. I ...
(Date:6/30/2015)... ... ... The United Nations Foundation’s Universal Access Project, in partnership with Planned Parenthood Federation ... today. Why We Care Youth serves as a platform for young people living in ... to them, and why U.S. policymakers should care about expanding access around the world. ...
(Date:6/30/2015)... ... June 30, 2015 , ... iData Research ( http://www.idataresearch.com ), ... reimbursement insurance policy tracking and analysis service. Reimbursement Tracker ™ enables medical ... updates in real-time from hundreds of insurance companies covering over 60,000 policies. ...
(Date:6/30/2015)... ... June 30, 2015 , ... Tulika ... Allegheny Health Network (AHN) as Director of its Adult Neuro-Oncology program. ... primary brain tumors, brain metastases, leptomeningeal disease and the neurological complications of cancer. ...
Breaking Medicine News(10 mins):Health News:GlobalSun – The First Sunscreen Developed for All People of Color – Hits The Market 2Health News:LifeAID Beverage Company Partners With The Adaptive Movement 2Health News:LifeAID Beverage Company Partners With The Adaptive Movement 3Health News:UN Foundation, Planned Parenthood Federation of America & Sierra Club Launch Why We Care Youth to Amplify Young Voices on Critical Importance of International Reproductive Health and Contraception 2Health News:UN Foundation, Planned Parenthood Federation of America & Sierra Club Launch Why We Care Youth to Amplify Young Voices on Critical Importance of International Reproductive Health and Contraception 3Health News:UN Foundation, Planned Parenthood Federation of America & Sierra Club Launch Why We Care Youth to Amplify Young Voices on Critical Importance of International Reproductive Health and Contraception 4Health News:iData Research Introduces New Medical Insurance Reimbursement Policy & Rate Tracker Subscription Service 2Health News:Noted Duke Brain Cancer Specialist to Direct Allegheny Health Network Neuro-Oncology Program 2Health News:Noted Duke Brain Cancer Specialist to Direct Allegheny Health Network Neuro-Oncology Program 3
... doctor's clinic, get a surgery and walk out in less ... an innovation in cataract surgery by Chennai-based doctor Amar Agarwal, ... promises to also allow patients to resume regular activities almost ... B.B. Eye Foundation here Sunday. ,The surgical procedure, designed ...
... Center had developed a novel way to assess sleep ... effective manner. They had reported in the journal Sleep ... the heartbeats// to develop the procedures that will successfully ... with it. ,Known as a “sleep spectrogram,” the ...
... Certain things in life are just taken for granted. But ... explanations to such things are projected. One such explanation is ... ,An analysis of the brain scans of 12 male subjects ... startling differences in the way the brain interprets the two ...
... dramatically reduce men's deaths from heart disease - even ... study.//The above finding holds good regardless of the cholesterol ... their risk of dying from cardiovascular disease if they ... and effect relationship with respect to cardiovascular disease discovered ...
... million doses of its flu vaccine, Fluarix. This dosage is ... amount of 8 million doses only represents about 10% of ... vaccines against flu.// The immense need for vaccination increased due ... recent years, due to the protection it offers against Influenza. ...
... published in the Food Technology journal, using bariatric operations ... time.// ,Operations performed on patients who must lose ... lives. But poor patient selection and incompletely studied complications ... the efficacy and safety of these procedures, reports the ...
Cached Medicine News:Health News:Have You Ever Wondered Why Male And Female Voices Differ? 2
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Each handle is designed to fit a specific trephine size....
Medicine Products: